These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9268193)

  • 1. Effect of a new monoclonal anti-glycoprotein IX antibody, KMP-9, on high shear-induced platelet aggregation.
    Miyake T; Nomura S; Komiyama Y; Miyazaki Y; Kagawa H; Masuda M; Takahashi H; Fujimura Y; Ikeda Y; Fukuhara S
    Thromb Haemost; 1997 Aug; 78(2):902-9. PubMed ID: 9268193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
    Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y
    Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-glycoprotein Ib causes platelet aggregation: different effects of blocking glycoprotein Ib and glycoprotein IIb/IIIa in the high shear filterometer.
    O'Brien JR; Etherington MD
    Blood Coagul Fibrinolysis; 1998 Sep; 9(6):453-61. PubMed ID: 9818994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
    Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
    Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
    Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel monoclonal antibody against the extracellular domain of GPIbbeta modulates vWF mediated platelet adhesion.
    Perrault C; Moog S; Rubinstein E; Santer M; Baas MJ; de la Salle C; Ravanat C; Dambach J; Freund M; Santoso S; Cazenave JP; Lanza F
    Thromb Haemost; 2001 Nov; 86(5):1238-48. PubMed ID: 11816713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
    Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
    Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cDNA cloning and molecular characterization of a snake venom platelet glycoprotein Ib-binding protein, mamushigin, from Agkistrodon halys blomhoffii venom.
    Sakurai Y; Fujimura Y; Kokubo T; Imamura K; Kawasaki T; Handa M; Suzuki M; Matsui T; Titani K; Yoshioka A
    Thromb Haemost; 1998 Jun; 79(6):1199-207. PubMed ID: 9657448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epinephrine and shear stress synergistically induce platelet aggregation via a mechanism that partially bypasses VWF-GP IB interactions.
    Wagner CT; Kroll MH; Chow TW; Hellums JD; Schafer AI
    Biorheology; 1996; 33(3):209-29. PubMed ID: 8935180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel tetrameric venom protein, agglucetin from Agkistrodon acutus, acts as a glycoprotein Ib agonist.
    Wang WJ; Huang TF
    Thromb Haemost; 2001 Oct; 86(4):1077-86. PubMed ID: 11686327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects?
    Xu G; Ulrichts H; Vauterin S; De Meyer SF; Deckmyn H; Teng M; Niu L
    Toxicon; 2005 Apr; 45(5):561-70. PubMed ID: 15777951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of purified 14-3-3 zeta signaling protein to discrete amino acid sequences within the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex.
    Andrews RK; Harris SJ; McNally T; Berndt MC
    Biochemistry; 1998 Jan; 37(2):638-47. PubMed ID: 9425086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the binding site for an alloantibody to von Willebrand factor which inhibits binding to glycoprotein Ib within the amino-terminal region flanking the A1 domain.
    Shibata M; Shima M; Fujimura Y; Takahashi Y; Nakai H; Sakurai Y; Asatani M; Nomura A; Take H; Giddings JC; Yoshioka A
    Thromb Haemost; 1999 May; 81(5):793-8. PubMed ID: 10365755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ristocetin- and thrombin-induced platelet aggregation at physiological shear rates: differential roles for GPIb and GPIIb-IIIa receptor.
    Kasirer-Friede A; Frojmovic MM
    Thromb Haemost; 1998 Sep; 80(3):428-36. PubMed ID: 9759623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
    Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
    Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibition of thrombus formation by anti-Willebrand monoclonal antibodies in the guinea pig].
    Cissé-Thiam M; Girma JP; Meyer D; Drouet L
    Dakar Med; 1999; 44(1):45-8. PubMed ID: 10797986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
    de Romeuf C; Hilbert L; Mazurier C
    Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists.
    Sirotkina OV; Khaspekova SG; Zabotina AM; Shimanova YV; Mazurov AV
    Platelets; 2007 Nov; 18(7):506-14. PubMed ID: 17957566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular abnormalities in Glanzmann's thrombasthenia, Bernard-Soulier syndrome, and platelet-type von Willebrand's disease.
    Clemetson KJ; Clemetson JM
    Curr Opin Hematol; 1994 Sep; 1(5):388-93. PubMed ID: 9371310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.